Research Solutions (NASDAQ:RSSS - Get Free Report) is expected to post its Q4 2025 results after the market closes on Thursday, September 18th. Analysts expect Research Solutions to post earnings of $0.03 per share and revenue of $12.5090 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Thursday, September 18, 2025 at 5:00 PM ET.
Research Solutions Trading Up 3.4%
Shares of Research Solutions stock opened at $3.33 on Thursday. The company has a market cap of $108.09 million, a price-to-earnings ratio of -23.78, a PEG ratio of 3.58 and a beta of 0.66. Research Solutions has a 1 year low of $2.32 and a 1 year high of $4.24. The company's fifty day simple moving average is $2.89 and its 200-day simple moving average is $2.82.
Institutional Trading of Research Solutions
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RSSS. Topline Capital Management LLC acquired a new position in shares of Research Solutions during the 2nd quarter worth about $125,000. Acadian Asset Management LLC lifted its holdings in shares of Research Solutions by 83.7% during the 1st quarter. Acadian Asset Management LLC now owns 87,327 shares of the company's stock valued at $225,000 after purchasing an additional 39,789 shares in the last quarter. Finally, NewEdge Advisors LLC acquired a new position in Research Solutions during the 1st quarter worth approximately $71,000. 33.60% of the stock is currently owned by institutional investors and hedge funds.
Research Solutions Company Profile
(
Get Free Report)
Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Research Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Research Solutions wasn't on the list.
While Research Solutions currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.